A new multiple sclerosis drug has been showing quite a promise in reducing relapse rates in people who suffer from the said disease. The experimental MS drug called alemtuzumab (Lemtrada) from Genzyme has been showing that it can reduce relapse rates of MS by as much as 50 percent. It is also seen to be
Researchers from The Scripps Research Institute in Florida have developed a new class of compounds that have shown to effectively halt the progression of MS in animal models. This new class of highly selective compounds may just lead the way for the researchers to find other more effective therapeutic routes for multiple sclerosis in humans.
Posted in Multiple Sclerosis 
Tags: immune system, ms drug, ms progression, ms research, ms treatment, new ms drug 
No Comments »
